[vc_row][vc_column][vc_column_text] This month, Dr. Gregory Reaman was named by the Childhood Cancer Data Initiative (CCDI) as the new Scientific Director. In this role, Dr. Reaman
[vc_row][vc_column][vc_column_text] Assorted News from the Last Week: The FDA has approved brentuximab vedotin (Adcetris) in combination with doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide (AVE-PC) in
Blogged with permission and thanks by the ACCELERATE Fit for Filing Working Group The ACCELERATE PLATFORM’S Fit for Filing (FFF) group was formed in 2019 to
[vc_row][vc_column][vc_column_text] Assorted News from the Last Week: November is National Family Caregivers Month. The President Joe Biden honored family caregivers for all they do for
The U.S. Food and Drug Administration issued a draft guidance that, when finalized, will provide the agency’s perspective on the ethical considerations for including and
[vc_row][vc_column][vc_column_text] Assorted News from the Last Week: CBS “Sunday Morning” contributor Kelefa Sanneh talked with CAC2 Members Kari and Tom Whitehead and their daughter Emily
Assorted News from the Last Week: Nearly one in four families of pediatric patients with acute lymphoblastic leukemia (ALL) enrolled in a clinical trial experienced
[vc_row][vc_column][vc_column_text] Assorted News from the Last Week: Pedmark (sodium thiosulfate) is now available to reduce the risk of ototoxicity associated with cisplatin in pediatric patients
Assorted News from the Last Week: Helping kids manage fear and anxiety when they have a serious illness Public sharing of pediatric brain cancer presentation
[vc_row][vc_column][vc_column_text] Assorted News from the Last Week: Making transformative advances against childhood cancer: A conversation with Dr. Doug Hawkins The FDA has approved sodium thiosulfate
